Luca Gianni - Dissemin

Papers authored by Luca Gianni

This paper is made freely available by the publisher.

2010 Lisa Carey, Eric Winer, Giuseppe Viale, David Cameron, Luca Gianni

Triple-negative breast cancer: Disease entity or title of convenience?

Download from www.nature.com

Distributing this paper is prohibited by the publisher

Pierantonio Menna, Emanuela Salvatorelli, Carlo Salsano, Luca Gianni

, Giorgio Minotti

Cardiovascular Toxicity of Antitumor Drugs: Translating Molecular Mechanisms into Clinical Facts

Upload

Luca Gianni

, Anna Lladó, Giulia Bianchi, Javier Cortes, Pirkko-Liisa Kellokumpu-Lehtinen, David A. Cameron, David Miles, Stefania Salvagni, Andrew M. Wardley, Jean-Charles Goeminne, Veronica Hersberger, José Baselga

Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

Download from doi.org

José Baselga, Karen A. Gelmon, Gelmon Ka, Shailendra Verma, Andrew M. Wardley, PierFranco Conte

, David Miles, Giulia Bianchi, Javier Cortes, Virginia A. McNally, Mc Nally Va, Ross Ga, Graham A. Ross, Pierre Fumoleau, Luca Gianni

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

Download from doi.org

This paper is available in a repository.

Luca Gianni

, Wolfgang Eiermann, Vladimir Semiglazov, Alexey Manikhas, Ana Lluch

, Sergey Tjulandin, Milvia Zambetti, Federico Vazquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Angel Climent, Eva Ciruelos, Belén Ojeda, Mauro Mansutti, Alla Bozhok and 6 other authors

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Download from www.researchgate.net

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

L. Gianni

An interview with Luca Gianni.

Upload

This paper was not found in any repository, but could be made available legally by the author.

2009 C. Sessa, D. Tosi, L. Viganò, J. Albanell, D. Hess, M. Maur, S. Cresta, A. Locatelli, R. Angst, F. Rojo, N. Coceani, V. M. Rivera, L. Berk, F. Haluska, L. Gianni

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

Upload

Luca Gianni

, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, Gabriel N. Hortobagyi

Role of Anthracyclines in the Treatment of Early Breast Cancer

Download from doi.org

C. Sessa, S. Cresta, C. Noberasco, G. Capri, E. Gallerani, F. De Braud, M. Zucchetti, M. D’Incalci, A. Locatelli, S. Marsoni, I. Corradino, C. Minoia, P. Zintl, L. Gianni

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours

Upload

Giulia Bianchi, Sibylle Loibl, Claudio Zamagni, Stefania Salvagni, Guenter Raab, Salvatore Siena, Nicole Laferriere, Carol Peña, Chetan Lathia, Loredana Bergamini, Luca Gianni

Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer:

Upload

Nicola Nicolai, Andrea Necchi, Luca Gianni

, Luigi Piva, Davide Biasoni

, Tullio Torelli, Silvia Stagni, Angelo Milani, Giorgio Pizzocaro, Roberto Salvioni

Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours

Upload

C. Sessa, A. Perotti, C. Noberasco, F. De Braud, E. Gallerani, S. Cresta, M. Zucchetti, L. Viganò, A. Locatelli, J. Jimeno, J. W. Feilchenfeldt, M. D’Incalci, G. Capri, N. Ielmini, L. Gianni

Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer

Upload

Luca Gianni

Never use anthracyclines with trastuzumab: It is time to reconsider the taboo

Download from hal.archives-ouvertes.fr

A. Perotti, C. Sessa, A. Mancuso, C. Noberasco, S. Cresta, A. Locatelli, M. L. Carcangiu, K. Passera, A. Braghetti, D. Scaramuzza, F. Zanaboni, A. Fasolo, G. Capri, M. Miani, W. P. Peters and 1 other authors

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours

Upload

Luca Gianni

, José Baselga, Wolfgang Eiermann, Vincente Guillem Porta, Vladimir Semiglazov, Ana Lluch